Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Dopamine Receptor Imaging in Mood Disorders

View source ↗

Summary

The NIMH-sponsored clinical trial evaluating dopamine receptor imaging in mood disorders has completed, with conditions including major depressive disorder and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Mood Disorders, Depressive Disorder, Major | Status: COMPLETED